Biocon - The ultimate biosimilars play!

[ashit]

Viatris Expects First “Interchangeable” Designation in July 2021 For Insulin Products | Goodwin - JDSupra.

At present Biocon/Mylan share in insulin is only 2.5% (roughly) this interchangeability may give real boost